Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve Announces Clearance of Next Generation 2.0 System in South Korea Dec 10, 2019 Viveve Announces Launch of Viveve 2.0 System in China Dec 3, 2019 Viveve Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option Nov 26, 2019 Viveve Announces Pricing of $10 Million Underwritten Public Offering Nov 22, 2019 Viveve Reports Third Quarter 2019 Financial Results and Provides Corporate Update Nov 7, 2019 Viveve to Host Conference Call to Provide Corporate Update and Third Quarter 2019 Results on November 7, 2019 Oct 24, 2019 Viveve Raises $6.76 million Through Completion of At-The-Market Equity Financing Oct 1, 2019 Viveve Submits Investigational Testing Application to Conduct Short-Term Feasibility Study in Stress Urinary Incontinence Sep 19, 2019 Viveve Announces Reverse Stock Split to Regain NASDAQ Compliance Sep 18, 2019 Viveve to Present at the Ladenburg Thalmann 2019 Healthcare Conference Sep 17, 2019 1 2 3 4 5 6 7 8 9 10 ...32
Viveve Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option Nov 26, 2019
Viveve to Host Conference Call to Provide Corporate Update and Third Quarter 2019 Results on November 7, 2019 Oct 24, 2019
Viveve Submits Investigational Testing Application to Conduct Short-Term Feasibility Study in Stress Urinary Incontinence Sep 19, 2019
